Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells

An obstacle to developing a vaccine against human respiratory syncytial virus (RSV) is that natural infection typically does not confer solid immunity to reinfection. To investigate methods to augment the immune response, recombinant RSV (rRSV) was constructed that expresses murine granulocyte-macro...

Cur síos iomlán

Sonraí bibleagrafaíochta

Foilsithe in:	J Virol
Príomhchruthaitheoirí:	Bukreyev, Alexander, Belyakov, Igor M., Berzofsky, Jay A., Murphy, Brian R., Collins, Peter L.
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	American Society for Microbiology (ASM) 2001
Ábhair:	Vaccines and Antiviral Agents
Rochtain ar líne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC116109/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11711604/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.75.24.12128-12140.2001
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!